Clark Estates’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.19M Hold
81,300
– – 0.74% 26
2026
Q2
$2.96M Hold
81,300
– – 0.68% 32
2026
Q1
$2.28M Buy
81,300
+14,000
+21% +$459K 0.55% 41
2025
Q4
$2.52M Hold
67,300
– – 0.61% 31
2025
Q3
$1.85M Buy
67,300
+7,300
+12% +$251K 0.42% 71
2025
Q2
$1.9M Hold
60,000
– – 0.43% 51
2025
Q1
$1.99M Buy
+60,000
New +$2.15M 0.42% 47

Other funds holding HRMY

Clark Estates's HRMY Position: Q3 2026 in Review

Clark Estates held its Harmony Biosciences (HRMY) position steady in Q3 2026 at 81,300 shares worth $3.19M. The position accounts for 0.74% of the portfolio, ranked #26.

Clark Estates first reported a position in HRMY in Q1 2025 and has held it in 7 quarters since. 279 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

  • Clark Estates held 81,300 shares of Harmony Biosciences worth $3.19M as of Q3 2026.
  • Clark Estates left its Harmony Biosciences share count unchanged in Q3 2026.
  • Harmony Biosciences made up 0.74% of Clark Estates's portfolio in Q3 2026, its #26 holding.
  • Clark Estates first reported a position in Harmony Biosciences in Q1 2025 and has held it in 7 quarters since.
  • 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Clark Estates's 13F filing for Q3 2026, filed 10 Nov 2026.